Zynerba Pharmaceuticals Inc
Drug Manufacturers-Specialty & Generic
Healthcare
ZYNE
48.43 M shares
NASDAQ US
traded
25 Sep 2023
listed
yes
open
1.32
52 week high
5.98
high
1.33
52 week low
1.32
low
1.32
growth
0.00 %
previous Close
1.34
P/E ratio
market cap
66.80 M
div yield
0
usd
Mar 2023
qoq
revenue
0.00 %
net incoming
-9.76 M
-28.09 %
eps
0.00 %
-16.67 %
eps surprise
-10.53 %
net profit margin
-975651100.00 %
0.00 %
operating incoming
-10.47 M
-20.55 %
net change in cash
-6.24 M
-17.89 %
cash on hand
44.40 M
-12.32 %
cost of revenue
0.00 %
top top